Ls Investment Advisors, LLC Exelixis, Inc. Transaction History

Ls Investment Advisors, LLC

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 11, 2021	SELL	$17.95 - $25.56 $355,769 - $506,599	-19,820 Closed	0 $0
Q1 2021 May 13, 2021	SELL	$20.53 - $25.22 $86,431 - $106,176	-4,210 Reduced 17.52%	19,820 $448,000
Q4 2020 Feb 10, 2021	BUY	$18.39 - $24.8 $22,546 - $30,404	1,226 Added 5.38%	24,030 $482,000
Q3 2020 Nov 12, 2020	SELL	$20.67 - $26.94 $10,541 - $13,739	-510 Reduced 2.19%	22,804 $558,000
Q2 2020 Aug 10, 2020	BUY	$16.46 - $27.42 $16,986 - $28,297	1,032 Added 4.63%	23,314 $553,000
Q4 2019 Jan 31, 2020	BUY	$15.15 - $18.89 $89,051 - $111,035	5,878 Added 35.83%	22,282 $393,000
Q3 2019 Oct 31, 2019	BUY	$17.68 - $22.65 $9,052 - $11,596	512 Added 3.22%	16,404 $290,000
Q2 2019 Aug 07, 2019	SELL	$18.93 - $24.75 $27,429 - $35,862	-1,449 Reduced 8.36%	15,892 $340,000
Q1 2019 Apr 25, 2019	SELL	$19.6 - $24.76 $8,114 - $10,250	-414 Reduced 2.33%	17,341 $413,000
Q4 2018 Feb 01, 2019	SELL	$13.65 - $21.8 $99,849 - $159,467	-7,315 Reduced 29.18%	17,755 $349,000
Q3 2018 Nov 13, 2018	BUY	$15.87 - $22.4 $143,718 - $202,854	9,056 Added 56.55%	25,070 $444,000
Q2 2018 Jul 20, 2018	BUY	$18.56 - $22.45 $297,219 - $359,514	16,014 New	16,014 $345,000

501

244M

2.54M

2.29M

Ticker EXEL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 321,832,000
Market Cap $11.5B
Description
Exelixis, Inc., an oncology-focused biotechnology company, focuses on the discovery, development, and commercialization of new medicines to treat cancers in the United States. The company's products include CABOMETYX tablets for the treatment of patients with advanced renal cell carcinoma who received prior anti-angiogenic therapy; and COMETRIQ ...

Get notified when there are updates to the investment portfolio of Ls Investment Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Ls Investment Advisors, LLC with notifications on news.